MENU

AGMB Agomab Therapeutics NV Forecast, Technical & Fundamental Analysis

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need... Show more

AGMB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
AGMB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NESYX67.040.67
+1.01%
Natixis US Equity Opportunities Y
VWIGX39.39N/A
N/A
Vanguard International Growth Inv
HFYRX16.26N/A
N/A
Hartford Schroders Intl Multi-Cp Val R3
ADCCX16.42N/A
N/A
American Century Disciplined Growth C
ESCKX18.33N/A
N/A
1290 Essex Small Cap Growth R
Agomab Therapeutics (AGMB) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com